Stock Market News

Sangamo stock holds Buy rating at H.C. Wainwright on Fabry therapy data

Jun 25, 2025 - 12:42
 0
Sangamo stock holds Buy rating at H.C. Wainwright on Fabry therapy data
Read More

Tags:

Previous Article

H.C. Wainwright reiterates buy rating on Anixa Biosciences stock

Next Article

Sarepta stock faces FDA scrutiny after liver failure deaths

Related Posts

Diaceutics shares rise on robust organic growth

Diaceutics shares rise on robust organic growth

May 13, 2025  0

Saudi Arabia partners with Nvidia to spur AI goals as Trump visits

Saudi Arabia partners with Nvidia to spur AI goals as T...

May 13, 2025  0

Poland stocks lower at close of trade; WIG30 down 0.71%

May 19, 2025  0